Incyte Corporation

The momentum for this stock is not very good. Incyte Corporation has good value characteristics. Incyte Corporation has good growth characteristics. Incyte Corporation is not very popular among insiders. Incyte Corporation is a mediocre stock to choose.
Log in to see more information.
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commerc...
INCY Fundamental Data by TradingView

News

Savant Capital LLC Lowers Position in Incyte Co. (NASDAQ:INCY)
Savant Capital LLC Lowers Position in Incyte Co. (NASDAQ:INCY)

Zolmax Savant Capital LLC cut its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 64.3% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...\n more…

National Bank of Canada FI Raises Stock Holdings in Incyte Co. (NASDAQ:INCY)
National Bank of Canada FI Raises Stock Holdings in Incyte Co. (NASDAQ:INCY)

Ticker Report National Bank of Canada FI lifted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 6.9% in the 2nd quarter, Holdings Channel reports. The firm owned 43,919 shares of the...\n more…

TD Asset Management Inc Has $5.23 Million Stake in Incyte Co. (NASDAQ:INCY)
TD Asset Management Inc Has $5.23 Million Stake in Incyte Co. (NASDAQ:INCY)

Ticker Report TD Asset Management Inc decreased its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 27.7% during the second quarter, according to the company in its most recent filing with the SEC...\n more…

Incyte Co. (NASDAQ:INCY) Shares Sold by Arizona State Retirement System
Incyte Co. (NASDAQ:INCY) Shares Sold by Arizona State Retirement System

Ticker Report Arizona State Retirement System reduced its position in Incyte Co. (NASDAQ:INCY - Free Report) by 17.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...\n more…

Incyte (NASDAQ:INCY) Receives "Neutral" Rating from Cantor Fitzgerald
Incyte (NASDAQ:INCY) Receives "Neutral" Rating from Cantor Fitzgerald

Ticker Report Cantor Fitzgerald restated their neutral rating on shares of Incyte (NASDAQ:INCY - Free Report) in a research report report published on Monday morning, Benzinga reports. Other equities research...\n more…

William Blair Reiterates "Outperform" Rating for Incyte (NASDAQ:INCY)
William Blair Reiterates "Outperform" Rating for Incyte (NASDAQ:INCY)

Zolmax William Blair restated their outperform rating on shares of Incyte (NASDAQ:INCY - Free Report) in a report issued on Monday morning, RTT News reports.\nINCY has been the topic of a number of other...\n more…